Augusta, GEORGIA3 Active Studies

Myasthenia Gravis Clinical Trials in Augusta, GEORGIA

Find 3 actively recruiting myasthenia gravis clinical trials in Augusta, GEORGIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
410
Enrolling

Recruiting Myasthenia Gravis Studies in Augusta

About Myasthenia Gravis Clinical Trials in Augusta

Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles responsible for breathing and movement. It occurs when communication between nerves and muscles is disrupted. Treatment includes medications that improve neuromuscular transmission and immunosuppressive therapies.

There are currently 3 myasthenia gravis clinical trials recruiting participants in Augusta, GEORGIA. These studies are seeking a combined 410 participants. Research is being sponsored by RemeGen Co., Ltd., Novartis Pharmaceuticals, NMD Pharma A/S. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myasthenia Gravis Clinical Trials in Augusta — FAQ

Are there myasthenia gravis clinical trials in Augusta?

Yes, there are 3 myasthenia gravis clinical trials currently recruiting in Augusta, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Augusta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.

Are clinical trials in Augusta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.

What myasthenia gravis treatments are being tested?

The 3 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for myasthenia gravis.

Data updated March 2, 2026 from ClinicalTrials.gov